askvity

What is Silent Leukemia?

Published in Leukemia 2 mins read

Silent leukemia refers to chronic lymphocytic leukemia (CLL) that is present without causing noticeable symptoms.

Essentially, individuals with silent leukemia have CLL, but the disease is detected incidentally, usually during a routine blood test performed for an unrelated reason. The reason it's "silent" is because the CLL isn't causing any noticeable symptoms or problems for the patient.

How is Silent Leukemia Detected?

  • Routine Blood Tests: The most common way silent leukemia is discovered is through a complete blood count (CBC) taken during a check-up or for diagnosing another condition. The CBC may reveal an elevated white blood cell count, specifically an increase in lymphocytes, which prompts further investigation.

Characteristics of Silent Leukemia:

  • Asymptomatic: Individuals experience no symptoms, such as fatigue, swollen lymph nodes, night sweats, or unexplained weight loss.
  • Slow Progression: The disease tends to progress very slowly, often remaining stable for years without requiring treatment.
  • Watchful Waiting: The initial approach to silent leukemia is usually "watchful waiting" or "active surveillance." This involves regular monitoring of blood counts and physical examinations to track the disease's progression. Treatment is only initiated when symptoms develop or if the leukemia shows signs of becoming more aggressive.

Why "Silent" CLL is Important:

  • Early Detection: While asymptomatic, early detection allows for monitoring and timely intervention if the disease progresses.
  • Avoidance of Unnecessary Treatment: Because CLL can be slow-growing, immediate treatment isn't always necessary. Watchful waiting helps avoid potential side effects from treatment when the disease isn't actively causing problems.

In summary, "silent leukemia" is CLL found in individuals without any apparent symptoms, typically discovered during routine bloodwork. The management strategy usually involves monitoring the disease's progression and initiating treatment only when symptoms appear or the disease becomes more active.

Related Articles